HAMBURG 2013 - September, 2013
A video summary of the sessions from EURETINA



Your 25-second video preview has ended.

to continue watching, please Log In or Register:

Log in / Register

  • Bookmark
  • Share this Video

Two-Year Outcomes in the IVAN Trial

by Usha Chakravarthy, MD, FRCS, FRCOphth, PhD

Usha Chakravarthy, MD, FRCS, FRCOphth, PhD, explains the results of a 24-month trial that investigated the differences between ranibizumab and bevacizumab in terms of safety and efficacy in a fixed-dose regimen versus an as-needed regimen.

9,572 video views since 9/19/2013.
100,458 total series views.

Comments (0)

Related Media